NCT05419180 - Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

June 13, 2024

Study Completion Date

June 13, 2024

Conditions

Pharmacoresistant Focal Epilepsies

Interventions

DRUG

Stiripentol

Since the treatment usually received by patients should not be modified, the sponsor will not intervene in any way in the therapeutic management of patients.

Trial Locations (1)

75015

Centre de Référence Epilepsies Rares / Centre Investigation Clinique (CIC) - Hôpital Necker-Enfants Malades, Paris